PALB2 and breast cancer: The rarity of PALB2 pathogenic variants may restrict the statistical power of our analysis, and larger scale cohorts of early-onset breast cancer require further assessment to determine whether there is a significant association between age at early onset and PALB2 pathogenic variants.